Evidence map›Paper›PMID 37768325›Full record

ArticleCytometry. Part A : the journal of the International Society for Analytical Cytology2023

OMIP-095: 40-Color spectral flow cytometry delineates all major leukocyte populations in murine lymphoid tissues.

Aris J Kare, Lisa Nichols, Ricardo Zermeno, Marina N Raie, Spencer K Tumbale, Katherine W Ferrara

Open access · bronzeAbstract read
In one paragraph

Article in Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Spectral Flow Cytometry: The Current State and Future of the Technology.International journal of molecular sciences · 2025
    Review
  8. OMIP-111: Immune-Profiling of T Helper 1 (Th1), Th2, and Th17 Signatures in Murine Splenocytes by Targeting Intracellular Cytokines.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Adipose tissue lymphocytes and obesity.The journal of cardiovascular aging · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Aris J KareDepartment of Bioengineering, Stanford University, Stanford, California, USA.ORCID 0000-0002-4896-2853
Lisa NicholsStanford Shared FACS Facility, Stanford University, Stanford, California, USA.ORCID 0000-0003-3635-0435
Ricardo ZermenoStanford Shared FACS Facility, Stanford University, Stanford, California, USA.
Marina N RaieDepartment of Radiology, Stanford University, Stanford, California, USA.ORCID 0000-0002-5549-404X
Spencer K TumbaleDepartment of Radiology, Stanford University, Stanford, California, USA.ORCID 0000-0002-0616-8280
Katherine W FerraraDepartment of Radiology, Stanford University, Stanford, California, USA.ORCID 0000-0002-4976-9107
Stanford University · US

Funding

Supplement to Enhance Wellness and Resiliency in the Graduate EnvironmentT32GM007276 · NIGMS · STANFORD UNIVERSITY · PI MORRISON, ASHBY J. · 1985 to 2023
$32.9M
Specific and high-resolution ultrasound cancer imagingR01CA112356 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI FERRARA, KATHERINE W, FOIRET, JOSQUIN · 2005 to 2022
$6.1M
In vivo PET imaging of novel engineered AAVs informs capsid design in Alzheimer's DiseaseR01EB028646 · NIBIB · STANFORD UNIVERSITY · PI FERRARA, KATHERINE W · 2019 to 2022
$3.8M
Imaging Modulation of Immune PhenotypeR01CA250557 · NCI · STANFORD UNIVERSITY · PI FERRARA, KATHERINE W, LEVY, RONALD · 2021 to 2025
$3.2M
HIFU-immunotherapy in pancreatic cancerR01CA253316 · NCI · STANFORD UNIVERSITY · PI FERRARA, KATHERINE W · 2020 to 2024
$3.1M
NCI NIH HHS R01 CA112356NCI NIH HHS R01 CA250557NCI NIH HHS R01 CA253316NIBIB NIH HHS R01 EB028646NIGMS NIH HHS T32 GM007276
6 · The paper itself

Abstract

High-dimensional immunoprofiling is essential for studying host response to immunotherapy, infection, and disease in murine model systems. However, the difficulty of multiparameter panel design combined with a lack of existing murine tools has prevented the comprehensive study of all major leukocyte phenotypes in a single assay. Herein, we present a 40-color flow cytometry panel for deep immunophenotyping of murine lymphoid tissues, including the spleen, blood, Peyer's patches, inguinal lymph nodes, bone marrow, and thymus. This panel uses a robust set of surface markers capable of differentiating leukocyte subsets without the use of intracellular staining, thus allowing for the use of cells in downstream functional experiments or multiomic analyses. Our panel classifies T cells, B cells, natural killer cells, innate lymphoid cells, monocytes, macrophages, dendritic cells, basophils, neutrophils, eosinophils, progenitors, and their functional subsets by using a series of co-stimulatory, checkpoint, activation, migration, and maturation markers. This tool has a multitude of systems immunology applications ranging from serial monitoring of circulating blood signatures to complex endpoint analysis, especially in pre-clinical settings where treatments can modulate leukocyte abundance and/or function. Ultimately, this 40-color panel resolves a diverse array of immune cells on the axes of time, tissue, and treatment, filling the niche for a modern tool dedicated to murine immunophenotyping.

Indexed as

Immunity, InnateLymphoid TissueAnimalsFlow CytometryImmunophenotypingKiller Cells, NaturalMiceT-Lymphocytescell sortingextracellular stainingfull spectrum flow cytometryinnate and adaptive immunitymurine immunophenotypingpre-clinical researchprimary and secondary lymphoid tissuessystems immunology

Identifiers

PMID37768325
PMCPMC10843696
OpenAlexW4387114623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.